AegirBio
Aegirbio signs agreement with Salofa for the veterinary market and receives a first order worth approximately SEK 2 million.
With this agreement, AegirBio will, via its subsidiary Magnasense Technologies OY, sell its existing MagniaReader to Salofa, which will bring it to market with proprietary tests for horses, dogs and cats. Magnasense receives revenue from the sale of instruments and royalties on the disposable products ie. tests that Salofa sells for the instruments.
When the contract was signed, an order was added to the value of 195,000 Euro (approx. SEK 2 million) for year one.
| Datum | 2023-07-07, kl 10:00 |
| Källa | Cision |
Alla Aktier tipsar: Nu får du 200 kr gratis när du skapar konto på Nordnet, insatt i fonden Nordnet One Balanserad. Bra tillfälle för dig som inte kommit igång med investeringar än, eller bara testat t.ex. Avanza.
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet